A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.

被引：4
|
作者：
Soliman, Hatem Hussein
Minton, Susan E.
Ismail-Khan, Roohi
Han, Hyo S.
Vahanlan, Nicholas N.
Ramsey, William Jay
Kennedy, Eugene
Link, Charles J.
Sullivan, Daniel
Antonia, Scott Joseph
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] NewLink Genet, Ames, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps3124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3124
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
  • [42] Phase II study of weekly docetaxel in patients with metastatic breast cancer
    Aihara, T
    Kim, Y
    Takatsuka, Y
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 286 - 292
  • [43] A phase I study of ABT-751 in combination with docetaxel in patients with metastatic hormone-refractory prostate cancer.
    Michels, J. E.
    Ellard, S.
    Le, L.
    Murray, N.
    Guns, E.
    Hagey, A.
    Chi, K. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 254S - 254S
  • [44] A phase I study of ABT-751 in combination with docetaxel in patients with metastatic hormone-refractory prostate cancer.
    Michels, J
    Ellard, S
    Le, LL
    Murray, N
    Guns, E
    Hagey, A
    Chi, KN
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9117S - 9117S
  • [45] Phase II study of perifosine in metastatic or advanced breast cancer.
    Leighl, NB
    Warr, D
    Vandenberg, T
    Dent, S
    Tannock, IF
    Crump, M
    Tozer, R
    Dancey, J
    Moore, MJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S67 - S68
  • [46] Phase I study of ifosfamide/doxorubicin in metastatic breast cancer.
    Aziz, Z
    Sana, S
    Sherazi, J
    Ilyas, N
    ANNALS OF ONCOLOGY, 2000, 11 : 36 - 36
  • [47] A phase Ib study of abemaciclib with therapies for metastatic breast cancer.
    Tolaney, Sara M.
    Beeram, Muralidhar
    Beck, J. Thaddeus
    Conlin, Alison Katherine
    Dees, Elizabeth Claire
    Dickler, Maura N.
    Helsten, Teresa L.
    Conkling, Paul R.
    Edenfield, William Jeffery
    Richards, Donald A.
    Turner, P. Kellie
    Cai, Na
    Chan, Edward Michael
    Pant, Shubham
    Becerra, Carlos
    Kalinsky, Kevin
    Puhalla, Shannon
    Rexer, Brent Neil
    Burris, Howard A.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
    Moulder, Stacy
    Gladish, Gregory
    Ensor, Joe
    Gonzalez-Angulo, Ana Maria
    Cristofanilli, Massimo
    Murray, James L.
    Booser, Daniel
    Giordano, Sharon H.
    Brewster, Abeena
    Moore, Julia
    Rivera, Edgardo
    Hortobagyi, Gabriel N.
    Tran, Hai T.
    CANCER, 2012, 118 (09) : 2378 - 2384
  • [49] Phase I study of docetaxel (D) in combination with epirubicin (E) as first line chemotherapy in metastatic breast cancer
    Borquez, D
    Raab, G
    Harstrick, A
    Wilke, HJ
    Achterrath, W
    Eiermann, W
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 : 29 - 29
  • [50] Phase II study of the combination of docetaxel, capecitabine and carboplatinum as first line therapy in metastatic breast cancer (MBC)
    Mokaddem, Walid
    Kattan, Joseph
    Chahine, Georges
    Nasr, Fadi
    Farhat, Fadi
    Tueni, Elias
    Dagher, Joya
    Younes, Fariha
    Ghosen, Marwan
    ANNALS OF ONCOLOGY, 2004, 15 : 45 - 46
12345